Month: November 2020

Nov 16 2020

Uncategorized

Rare and Possibly Life-Threatening Sensitivity to Key Schizophrenia Tx

by Clinical Editor

No Comments

A 22-year-old Hispanic man with schizophrenia is placed on an involuntary hold and admitted to an inpatient psychiatric unit in California after experiencing auditory, visual, and tactile …

Nov 16 2020

Uncategorized

Improving the Design of Clinical Trials of Drugs to Treat Schizophrenia

by Clinical Editor

No Comments

CDER research has identified ways to streamline schizophrenia drug trials without compromising their sensitivity.

Nov 16 2020

Uncategorized

Cerevel Therapeutics Announces Third Quarter 2020 Financial Results and Key Business Highlights

by Clinical Editor

No Comments

Participants dosed in clinical trials for lead programs in schizophrenia, epilepsy, anxiety and Parkinson’s diseaseDebuted as publicly traded …

Nov 16 2020

Uncategorized

Lithium treatments used for bipolar disorder shown to help fish fight parasite

by Clinical Editor

No Comments

Treatments used for people with bipolar disorder have been shown to help fish ward off a parasite, a new study shows.

Nov 16 2020

Uncategorized

Study uses polygenic risk scores to determine schizophrenia risk in patients with chromosome deletion syndrome

by Clinical Editor

No Comments

A new study involving researchers from Children’s Hospital of Philadelphia (CHOP) has uncovered genetic clues that may help identify which patients with chromosome 22q11.2 deletion syndrome (22q11.2DS …

Nov 15 2020

Uncategorized

Rare and Possibly Life-Threatening Sensitivity to Key Schizophrenia Tx

by Clinical Editor

No Comments

A 22-year-old Hispanic man with schizophrenia is placed on an involuntary hold and admitted to an inpatient psychiatric unit in California after experiencing auditory, visual, and tactile …

Nov 15 2020

Uncategorized

Finding the Right Treatment for Schizophrenia

by Clinical Editor

No Comments

Some people with schizophrenia turn to drugs or alcohol to cope. A disproportionate number end up homeless. Even so, experts note that many individuals with schizophrenia are able, with treatment...

Nov 15 2020

Uncategorized

Study uses polygenic risk scores to determine schizophrenia risk in patients with chromosome deletion syndrome

by Clinical Editor

No Comments

A new study involving researchers from Children’s Hospital of Philadelphia (CHOP) has uncovered genetic clues that may help identify which patients with chromosome 22q11.2 deletion syndrome (22q11.2DS …

Nov 15 2020

Uncategorized

Improving the Design of Clinical Trials of Drugs to Treat Schizophrenia

by Clinical Editor

No Comments

CDER research has identified ways to streamline schizophrenia drug trials without compromising their sensitivity.

Nov 15 2020

Uncategorized

Schizophrenia Epidemiology 2017-2030 by Prevalent Cases, Diagnosed Prevalent, Gender, Age, Region

by Clinical Editor

No Comments

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Prevalent Cases of schizophrenia, Diagnosed Prevalent cases of schizophrenia, …